130 related articles for article (PubMed ID: 7095004)
1. Detection and comparative evaluation of aldosterone antagonists in glucocorticoid-treated, adrenalectomized rats.
Casals-Stenzel J; Buse M; Losert W
Eur J Pharmacol; 1982 May; 80(1):37-45. PubMed ID: 7095004
[TBL] [Abstract][Full Text] [Related]
2. Progestogens with antimineralocorticoid activity.
Losert W; Casals-Stenzel J; Buse M
Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
[TBL] [Abstract][Full Text] [Related]
3. Improved method for comparative evaluation of aldosterone antagonists in healthy man.
Casals-Stenzel J; Schmalbach J; Losert W
Eur J Clin Pharmacol; 1977 Dec; 12(4):247-55. PubMed ID: 590311
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of canrenoate-K and prorenoate-K upon aldosterone biosynthesis in perifused frog interrenal glands.
Delarue C; Leboulenger F; Tonon MC; Jegou S; Leroux P; Kusmierek MC; Corvol P; Vaillant R; Vaudry H
Steroids; 1979 Sep; 34(3):319-32. PubMed ID: 494369
[TBL] [Abstract][Full Text] [Related]
5. Potassium prorenoate: a new steroidal aldosterone antagonist.
Hofmann LM; Chinn LJ; Pedrera HA; Krupnick MI; Suleymanov OD
J Pharmacol Exp Ther; 1975 Aug; 194(2):450-6. PubMed ID: 1151770
[TBL] [Abstract][Full Text] [Related]
6. Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
Losert W; Bittler D; Buse M; Casals-Stenzel J; Haberey M; Laurent H; Nickisch K; Schillinger E; Wiechert R
Arzneimittelforschung; 1986 Nov; 36(11):1583-600. PubMed ID: 3028435
[TBL] [Abstract][Full Text] [Related]
7. Effect of aldosterone antagonists on aldosterone-induced activation of Mg2+ -HCO3- -ATPase and carbonic anhydrase in rat intestinal mucosa.
Suzuki S; Takamura S; Yoshida J; Ozaki N
J Steroid Biochem; 1985 Jul; 23(1):57-66. PubMed ID: 3160893
[TBL] [Abstract][Full Text] [Related]
8. Relative potency of prorenoate and spironolactone in normal man.
Ramsay L; Harrison I; Shelton J; Tidd M
Clin Pharmacol Ther; 1975 Oct; 18(4):391-400. PubMed ID: 1100306
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone.
Levine D; Ramsay L; Auty R; Branch R; Tidd M
Eur J Clin Pharmacol; 1976 Mar; 09(5-6):381-6. PubMed ID: 786663
[TBL] [Abstract][Full Text] [Related]
10. Localization of Na,K-ATPase activity in developing rat distal colon: role of corticosteroids.
Zemanová Z; Pácha J
Mech Ageing Dev; 1998 Mar; 101(1-2):129-43. PubMed ID: 9593319
[TBL] [Abstract][Full Text] [Related]
11. Intracerebroventricular infusion of aldosterone induces hypertension in rats.
Gomez-Sanchez EP
Endocrinology; 1986 Feb; 118(2):819-23. PubMed ID: 3943493
[TBL] [Abstract][Full Text] [Related]
12. Effect of aldosterone antagonists on mineralocorticoid synthesis in vitro. Inhibition of aldosterone production by prorenoate-K.
Netchitailo P; Delarue C; Perroteau I; Jegou S; Tonon MC; Leroux P; Leboulenger F; Kusmierek MC; Capron MH; Vaudry H
Eur J Pharmacol; 1982 Feb; 77(4):243-9. PubMed ID: 6277668
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of a new antialdosterone compound, prorenone.
Claire M; Rafestin-Oblin ME; Michaud A; Roth-Meyer C; Corvol P
Endocrinology; 1979 Apr; 104(4):1194-200. PubMed ID: 436757
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute mineralocorticoid and glucocorticoid receptor blockade on the excretion of an acute potassium load in healthy humans.
van Buren M; Boer P; Koomans HA
J Clin Endocrinol Metab; 1993 Oct; 77(4):902-9. PubMed ID: 8408463
[TBL] [Abstract][Full Text] [Related]
15. Mineralo- and glucocorticoid effects on renal excretion of electrolytes.
Campen TJ; Vaughn DA; Fanestil DD
Pflugers Arch; 1983 Oct; 399(2):93-101. PubMed ID: 6647008
[TBL] [Abstract][Full Text] [Related]
16. Steady-state relative potency of aldosterone antagonists: spironolactone and prorenoate.
McInnes GT; Shelton JR; Harrison IR
Clin Pharmacol Ther; 1981 May; 29(5):679-86. PubMed ID: 7214797
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of aldosterone-induced antinatriuresis and kaliuresis by actinomycin D.
Horisberger JD; Diezi J
Am J Physiol; 1984 Feb; 246(2 Pt 2):F201-4. PubMed ID: 6696121
[TBL] [Abstract][Full Text] [Related]
18. Effect of aldosterone on potassium excretion during potassium chloride infusion in sheep.
Rabinowitz L; Sarason RL; Yamauchi H
Am J Physiol; 1985 Oct; 249(4 Pt 2):R455-61. PubMed ID: 4051031
[TBL] [Abstract][Full Text] [Related]
19. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
[TBL] [Abstract][Full Text] [Related]
20. Relative potency of prorenoate potassium and spironolactone in attenuating diuretic induced hypokalaemia.
McInnes GT; Harrison IR; Shelton JR; Perkins RM; Clarke JM
Br J Clin Pharmacol; 1984 Aug; 18(2):169-74. PubMed ID: 6487456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
